HARMONY BIOSCIENCES ANNOUNCES 2022 FUNDING RECIPIENTS OF PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD PROGRAMS

/PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative...

Related Keywords

New York ,United States ,Columbia University ,Washington Heights ,American ,Nancy Leone ,Luis Sanay ,Corporate Affairs Officer ,World Sleep Society ,International Sleep Medicine Examination ,World Sleep Society Medicine Examination ,Prnewswire Harmony Biosciences Holdings Inc ,Division Of Cardiology ,Public Health ,Prader Willi Syndrome Association United States ,Diverse Population Of High School Students ,Diversity Leadership Program ,Muscular Dystrophy Association ,Interactive Forum For Relational Connections ,Hypersomnia Foundation ,Community Programs ,Disparity Task Force Initiative ,International Sleep Medicine Exam ,American Academy Of Neurology ,Strategic Communications For Awareness ,Paragon Biosciences ,Biosciences Holdings ,World Narcolepsy Day ,Harmony Biosciences ,Cate Mccanless ,Chief Corporate Affairs ,Dystrophy Association ,Peer To Relational ,Strategic Communications ,Kleine Levin Syndrome ,Willi Syndrome Association ,Sleep Society ,Censuring Equity ,Patient Owned Data ,Task Force ,Hispanic American ,Reinforcing Essentials ,Diverse Population ,High School Students ,New York City ,Diversity Leadership ,American Academy ,Plymouth Meeting ,Biosciences Media Contact ,Biosciences Investor Contact ,